BNP PARIBAS FINANCIAL MARKETS - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2020$3,122,847,000
+46.5%
2,368,000
+20.2%
0.01%
+50.0%
Q4 2019$2,131,205,000
+7.0%
1,970,000
+1.5%
0.00%0.0%
Q3 2019$1,991,311,000
-49.7%
1,941,000
-45.0%
0.00%
-50.0%
Q2 2019$3,962,763,000
-0.4%
3,532,000
+0.6%
0.01%
-11.1%
Q1 2019$3,980,094,000
+628.7%
3,510,000
+619.3%
0.01%
+800.0%
Q4 2018$546,209,000
-99.3%
488,000
-33.6%
0.00%
-98.6%
Q3 2014$80,482,496,000
-74.5%
735,000
-75.5%
0.07%
-76.4%
Q2 2014$315,929,984,0003,000,0000.30%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q1 2020
NameSharesValueWeighting ↓
SCHRODER INVESTMENT MANAGEMENT GROUP 12,400,000$1,340,750,000,0001.66%
OAKTREE CAPITAL MANAGEMENT LP 66,800,000$70,446,0001.23%
Man Investments (CH) AG 2,600,000$2,743,0001.11%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$8,425,0000.81%
ADVENT CAPITAL MANAGEMENT /DE/ 35,763,000$38,870,0000.58%
Jabre Capital Partners S.A. 5,900,000$6,240,0000.44%
SSI INVESTMENT MANAGEMENT LLC 3,039,000$3,198,0000.31%
AVIVA PLC 37,700,000$39,724,0000.30%
BNP PARIBAS FINANCIAL MARKETS 3,000,000$315,929,984,0000.30%
Calamos Advisors LLC 44,222,000$46,596,0000.30%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders